CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


<
Adamas Pharmaceuticals Inc  (ADMS)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 


 

Adamas Pharmaceuticals Inc

ADMS's Financial Statements and Analysis






Adamas Pharmaceuticals Inc increased III. Quarter net loss per share of $-1.04 compare to net loss per share of $-0.66 recorded in the same quarter a year ago a decrease compare to $-0.93 realized in previous quarter.

Adamas Pharmaceuticals Inc's Revenue fell by % in III. Quarter (Sep 30 2017) year on year, to $0 million and declined by -50 % sequentially.


Adamas Pharmaceuticals Inc is
More on ADMS's Income Statement

III. Quarter
Earnings Per Share Revenues
$ -1.04 $  0 Mill
$-0.38     Unch.     -99.28 %
You need to upgrade your Flash Player
ADMS's NET INCOME

Adamas Pharmaceuticals Inc's in III. Quarter recorded net loss of $-23 million, an increase from net loss of $-14 million in III. Quarter a year ago.

Sequentially net loss advanced

More on ADMS's Growth

In III. Quarter company's net cash and cash equivalents decreased by $-12 million, capital expenditures fell by -1,531.82%, to $-0 millions compare to same quarter a year ago and fell by 22.57% from II. Quarter (Jun 30 2017).

More on ADMS's Cash flow Statement



Adamas Pharmaceuticals Inc does not pay out common stock dividend.

In trailing twelve-month period Adamas Pharmaceuticals Inc payed $ -2.29 cash per share, on a free-cash flow basis .

Book value fell by -18.00 % sequentially to $3.81 per share, -24.78% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 3.81 per share from $ 4.64.

Company issued 0.18 million shares or 0.79 % in III. Quarter.


More on ADMS's Dividends
 Market Capitalization (Millions) 825
 Shares Outstanding (Millions) 23
 Total Debt (Millions $) 35
 Revenue (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -75
 Cash Flow (TTM) (Millions $) 12
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -





Adamas Pharmaceuticals Inc does not pay out common stock dividend.

In trailing twelve-month period Adamas Pharmaceuticals Inc payed $ -2.29 cash per share, on a free-cash flow basis .

Book value fell by -18.00 % sequentially to $3.81 per share, -24.78% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 3.81 per share from $ 4.64.

Company issued 0.18 million shares or 0.79 % in III. Quarter.


More on ADMS's Dividends
 Market Capitalization (Millions) 825
 Shares Outstanding (Millions) 23
 Total Debt (Millions $) 35
 Revenue (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -75
 Cash Flow (TTM) (Millions $) 12
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -


   

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BBY's Profile

Stock Price

BBY's Financials

BBY's Expectations

Business Description

Fundamentals

Charts & Quotes

BBY's News

Suppliers

BBY's Competitors

Customers & Markets

Economic Indicators

BBY's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com